|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 9/0095 | (2013.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61K 9/2054 | (2013.01) | ||
| A61K 31/454 | (2006.01) | ||
| A61K 9/2059 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/454 | (2013.01) | ||
| A61P 35/02 | (2006.01) | ||
| A61K 31/4439 | (2013.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61J 3/10 | (2013.01) | ||
| A61J 3/10 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61K 9/0056 | (2013.01) |
| (11) | Number of the document | 3200772 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15778761.5 |
| Date of filing the European patent application | 2015-10-01 | |
| (97) | Date of publication of the European application | 2017-08-09 |
| (45) | Date of publication and mention of the grant of the patent | 2022-08-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2015/057523 |
| Date | 2015-10-01 |
| (87) | Number | WO 2016/051374 |
| Date | 2016-04-07 |
| (30) | Number | Date | Country code |
| 201462059331 P | 2014-10-03 | US |
| (72) |
ELBAZ, Frantz , CH
KOCHHAR, Charu , CH
STINGELIN, Doris , CH
BOCK, Michaela Anna Maria , CH
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PHARMACEUTICAL COMPOSITIONS COMPRISING ALPELISIB |
| PHARMACEUTICAL COMPOSITIONS COMPRISING ALPELISIB |